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Abstract. 
 
Little is known about the mechanisms of in-
tracellular targeting of viral nucleic acids within in-
fected cells. We used in situ hybridization to visualize 
the distribution of tobacco mosaic virus (TMV) viral 
 
RNA (vRNA) in infected tobacco protoplasts. Immuno-
staining of the ER lumenal binding protein (BiP) con-
current with in situ hybridization revealed that vRNA 
colocalized with the ER, including perinuclear ER. At 
midstages of infection, vRNA accumulated in large ir-
regular bodies associated with cytoplasmic ﬁlaments 
while at late stages, vRNA was dispersed throughout 
the cytoplasm and was associated with hair-like protru-
sions from the plasma membrane containing ER. TMV 
movement protein (MP) and replicase colocalized with 
vRNA, suggesting that viral replication and translation 
occur in the same subcellular sites. Immunostaining 
with tubulin provided evidence of colocalization of 
vRNA with microtubules, while disruption of the cy-
toskeleton with pharmacological agents produced se-
vere changes in vRNA localization. Mutants of TMV 
lacking functional MP accumulated vRNA, but the dis-
tribution of vRNA was different from that observed in 
wild-type infection. MP was not required for associa-
tion of vRNA with perinuclear ER, but was required 
for the formation of the large irregular bodies and asso-
ciation of vRNA with the hair-like protrusions.
Key words: in situ
 
 
 
hybridization • tobacco mosaic vi-
rus • virus replication • endoplasmic reticulum • cy-
toskeleton
 
S
 
PECIFIC
 
 virus–host interactions determine the capa-
bility of viruses to successfully replicate in a cell and
spread local and systemically in the host. Plant vi-
ruses, like those of animals, compartmentalize viral RNA
synthesis by association with the cellular endomembrane
system (e.g., Restrepo-Hartwig and Carrington, 1994; Re-
strepo-Hartwig and Ahlquist, 1996; Schaad et al., 1997;
Ward et al., 1997). However, despite their central role in
viral pathology, little is known about how viral RNA–pro-
tein complexes are transported through the cytoplasm, an-
chored and replicated in cellular membranes, and targeted
to plasmodesmata to initiate spread to adjacent plant cells.
Defining those mechanisms will give new insights about
the specific virus–host interactions that ultimately deter-
mine a successful viral infection.
Tobacco mosaic virus (TMV)
 
1
 
 is the type member of the
tobamovirus group. The genome of TMV consists of one
single-stranded 6.4-kb RNA containing four open reading
frames. The genomic RNA serves as messenger RNA
(mRNA) for the production of a 126-kD protein and, by
readthrough of an amber termination codon, a 183-kD
protein (Beier et al., 1984). Both proteins are involved in
 
replication of viral RNA (Ishikawa et al., 1986). The 30-kD
movement protein (MP), which is required for cell-to-cell
movement (Deom et al., 1987), and the 17.5-kD coat pro-
tein (CP) are dispensable for replication (Meshi et al.,
1987; Takamatsu et al., 1987).
Cytological (Bald, 1964) and radioautographic studies
(Smith and Schlegel, 1965) suggested that replication of
TMV RNA was associated with the nucleus. However,
other approaches later showed that double-stranded repli-
cative intermediates of TMV RNA (Ralph et al., 1971;
Nilsson-Tillgren et al., 1974; Beachy and Zaitlin, 1975) and
virus-specific RNA-dependent RNA polymerase (Zaitlin
et al., 1973; Osman and Buck, 1996) were localized and/
or associated with cellular cytoplasmic membranes. Bio-
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chemical fractionation of TMV-infected protoplasts re-
vealed that TMV minus-strand RNA accumulated prima-
rily in a cytoplasmic, extranuclear fraction (Okamoto et al.,
1988).
Cytological analyses of TMV-infected cells showed virus
replication complexes associated with cytoplasmic inclu-
sions, called viroplasms, which expanded throughout the
infection. These inclusions contained ribosomes, tubules,
and 126/183-kD replication proteins (Esau and Cronshaw,
1967; Martelli and Russo, 1977; Hills et al., 1987; Saito
et al., 1987). Recent studies with TMV that encodes MP:
green fluorescent protein (GFP) fusion protein have sug-
gested that the fluorescent irregularly shaped structures
in cells that contain MP and replicase were derived from
the ER membranes (Heinlein et al., 1998; Reichel and
Beachy, 1998).
Since the MP binds single-stranded nucleic acids in vitro
(Citovsky et al., 1990) and accumulates in plasmodesmata
(Tomenius et al., 1987; Deom et al., 1990), apparently in-
creasing the plasmodesmata size exclusion limit (Wolf et al.,
1989; Oparka et al., 1997), it was suggested that the MP
and viral TMV RNA form ribonucleoprotein complexes
that are directed to and transported through plasmodes-
mata (Citovsky and Zambryski, 1991). Colocalization of
the MP with microtubules (Heinlein et al., 1995) and mi-
crofilaments (McLean et al., 1995) prompted the hypothe-
sis that elements of the cytoskeleton play a role in the in-
tracellular transport of the MP-viral RNA complexes
(Zambryski, 1995; Carrington et al., 1996). However, the
specific sites of viral RNA accumulation are not known;
likewise, it is not known if cytoskeletal components are as-
sociated with viral RNA.
In many different biological systems, the coordinated
activities of components of the cytoskeleton are responsi-
ble for the specific transport of RNAs, as well as the an-
choring of RNAs at their final locations (e.g., Wilhelm and
Vale, 1993; Hovland et al., 1996; Bassell and Singer, 1997;
Gavis, 1997; Arn and Macdonald, 1998; Hazelrigg, 1998).
In some cases, mRNAs are transported as RNA–protein
complexes or “granular particles” (e.g., Ainger et al., 1993;
Kloc and Etkin, 1993; Forristal et al., 1995; Broadus et al.,
1998; Schuldt et al., 1998) that are formed by RNA–RNA
and RNA–protein interactions (Ferrandon et al., 1998).
Recent observations suggest that in different cell types,
the RNA-binding protein involved in the formation of an
RNA–protein complex may mediate RNA localization by
using different cytoskeletal components (Oleynikov and
Singer, 1998).
In this work, nonradioactive methods of in situ hybrid-
ization were used to localize the intracellular distribution
of TMV RNA during virus infection. The combined use of
immunostaining and in situ hybridization techniques al-
lowed examination of the relationship between the sites of
vRNA accumulation and the distribution of selected host
(microtubules, ER) and viral (MP, replicase) components.
The pattern of vRNA accumulation after treatment with
oryzalin and cytochalasin D gave new insights about the
role of actin filaments and microtubules in vRNA trans-
port and replication. Furthermore, the use of TMV deriva-
tives lacking a functional MP allowed us to determine the
role of the MP in establishing the sites of vRNA infection
and association with host components.
 
Materials and Methods
 
Plasmids
 
Diagrams of the infectious clones used in this study are shown in Fig. 1 A
(below). The plasmids pU3/12 (Holt and Beachy, 1991) and pU3/12 
 
D
 
M-
RV (Nejidat et al., 1991) were used to generate infectious transcripts of
wild-type (wt) TMV and TMV that does not express a functional MP
(
 
D
 
M), respectively. The plasmids pT-MfCP (MP:GFP-CP) and pTMV-M:
GfusBr (MP:GFP-
 
D
 
C) (Oparka et al., 1997) contain the MP fused to GFP
in which serine at amino acid position 65 is replaced by threonine (Heim
et al., 1995). vRNA-MP:GFP-
 
D
 
C does not contain the CP open reading
frame (see Fig. 1 A).
The plasmid pTR447 was used as template to produce the nonradioac-
tive (digoxigenin or fluorescein) labeled RNA probes used in Northern
blot and in situ hybridization experiments. To create pTR447, the XbaI–
HindIII fragment of the TMV replicase coding sequence (comprising nu-
cleotides 999 to 1446) was removed from pU3/12 
 
D
 
M-RV and subcloned
into the plasmid vector Bluescript SK
 
1
 
 (Stratagene Inc.) previously di-
gested with the same restriction endonucleases.
 
Protoplast Infection, RNA Extraction, and Northern 
Hybridization Analysis
 
Infectious RNAs were obtained by in vitro transcription of TMV clones
using the MEGAscript T7 kit (Ambion Inc.). Protoplasts were transfected
by electroporation as described by Watanabe et al. (1987) and collected
by centrifugation at 4, 8, 14, 20, and 30 h post-infection (hpi). Total RNA
was isolated from 5 
 
3
 
 10
 
4
 
 protoplasts using TRIzol reagent following the
recommendations of the manufacturer (GIBCO-BRL). RNA was recov-
ered from the aqueous phase after centrifugation at 12,000 
 
g 
 
for 15 min at
4
 
8
 
C, precipitated with isopropanol, and resuspended in an adequate vol-
ume of sterile water.
To monitor plus- and minus-strand accumulation, the RNAs were de-
natured with glyoxal following the procedure described by McMaster and
Carmichel (1977). RNAs extracted from equal numbers of protoplasts
were loaded onto the gel and electrophoresed in 20 mM Hepes, pH 7.00,
1 mM EDTA. After electrophoresis, the gels were soaked in 50 mM
NaOH for 15 min and 50 mM sodium acetate/acetic acid for an additional
15 min. The nucleic acids were then transferred to nitrocellulose mem-
branes in 10
 
3
 
 SSC (1.5 M NaCl, 0.15 M sodium citrate, pH 7.0) according
to standard procedures (Sambrook et al., 1989). Before hybridization, the
membranes were stained with methylene blue (Sambrook et al., 1989) to
verify that the levels of ribosomal RNA in each sample were similar.
Prehybridization, hybridization, and colorimetric detection were per-
formed as previously described by Más and Pallás (1996). Single-stranded
digoxigenin-RNA probes that recognized plus or minus strands of the ge-
nomic TMV RNA were obtained by in vitro transcription of the plasmid
pTR447 clone previously linearized with XbaI or HindIII and using T7 or
T3 RNA polymerases, respectively (Boehringer Mannheim Biochemi-
cals).
 
Immunofluorescent Labeling
 
Protoplasts were fixed in paraformaldehyde and spun onto polylysine-
coated slides (Sigma Chemical Co.) as described by Kahn et al. (1998).
For immunostaining, the samples were washed two times in PBS-TE
buffer (140 mM NaCl, 2.5 mM KCl, 10 mM Na
 
2
 
HPO
 
4
 
, 1.5 mM KH
 
2
 
PO
 
4
 
,
0.5% Tween 20, and 5 mM EGTA). The slides were then immersed in
cold methanol for 10 min and washed again in PBS-TE before incubation
for 2 h at room temperature with the primary antibody. Monoclonal
mouse anti–
 
a
 
-tubulin and anti–actin antibodies (Amersham Corp.) were
diluted 1:100 in PBS-TE. The antibody against the rabbit anti–ER lume-
nal binding protein (BiP), kindly provided by R.S. Boston (North Caro-
line State University, Raleigh, NC), was used at 1:100 dilution in PBS-TE.
To immunolocalize TMV replicase, a polyclonal antibody against the 126/
183-kD replicase protein (Nelson et al., 1993) was diluted 1:50 in PBS-TE.
After incubation with the primary antibody, the samples were washed two
times in PBS-TE and incubated for 2 h at room temperature with 1:100 di-
lution of the secondary antibody:TRITC-conjugated goat anti–mouse IgG
(Jackson ImmunoResearch Laboratories, Inc.) or TRITC-conjugated
goat anti–rabbit IgG (Pierce Chemical Co.). The samples were then
washed again and either mounted in Mowiol (Calbiochem Corp.) or pro-
cessed by in situ hybridization to detect vRNA. 
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In Situ Hybridization
 
Before hybridization, the samples were treated with proteinase K (1 
 
m
 
g/ml)
for 5 min, washed, and refixed with paraformaldehyde at room tempera-
ture for 30 min. After fixation, the samples were washed again and im-
mersed in 0.25% acetic anhydride, 100 mM triethanolamine-HCl, pH 8.0,
for 10 min to prevent nonspecific binding of the probe to positively
charged amino groups. After acetylation, the samples were dehydrated by
10 min washes in 70, 80, 90, 95, and 100% ethanol solutions. The samples
were then hybridized overnight at 55
 
8
 
C in a moist chamber with the hy-
bridization solution containing 50% (vol/vol) of deionized formamide, 4
 
3
 
SSC, 0.1% (wt/vol) SDS, 8% (wt/vol) dextran sulphate, and 10 ng/
 
m
 
l of
fluorescein-RNA (fluor-RNA) probe. The fluor-RNA probes that recog-
nized plus or minus strand of the genomic TMV RNA were obtained by in
vitro transcription of pTR447 as described above. Probes were labeled
with fluorescein-12-UTP (Boehringer Mannheim Biochemicals) following
the recommendations of the manufacturer. After hybridization, the sam-
ples were washed two times in 2
 
3
 
 SSC for 10 min at room temperature
and two times in 0.1
 
3
 
 SSC for 10 min at 50
 
8
 
C, air-dried, and mounted as
described above.
 
Treatment with Cytoskeleton Depolymeration Agents
 
To disrupt microtubules, infected protoplasts were treated with 10 
 
m
 
M
oryzalin (ChemService) for 2 h. To disrupt microfilaments, infected proto-
plasts were treated with 100 
 
m
 
M cytochalasin D (Calbiochem Corp.) for
2 h. Stock solutions of oryzalin and cytochalasin D were prepared in
DMSO so that the final concentration of DMSO added to the protoplasts
did not exceed 0.1% (vol/vol). After these treatments, the protoplasts
were fixed and processed for in situ hybridization following the procedure
described above.
 
Confocal Microscopy
 
Confocal imaging was performed as previously described (Más and
Beachy, 1998) using a confocal laser scanning microscope (IX70; Olym-
pus Corp.). Optical sections were made at 0.8-
 
m
 
m intervals and projec-
tions of serial optical sections were obtained using the software provided
by the manufacturer. To examine fluorescein and GFP fluorescence, opti-
cal planes were scanned with the 488-nm argon laser using a 550-nm
(FVX-BA550RIF) barrier filter and 60
 
3
 
 1.4 NA PlanApo or 100
 
3
 
 1.35
NA UPlanApo oil-immersion objectives. The TRITC signal was detected
with the 568-nm krypton laser (FVX-BA585IF). In experiments of dual
localization (with fluorescein and TRITC), both fluorophores were exam-
ined independently, or by attenuating the 488-nm line to 25% intensity to
reduce the possibility of crossover between the channels. Furthermore,
single immunodetection controls verified the absence of fluorescence
crossover.
 
Results
 
Northern Hybridization of Protoplasts Infected
with TMV
 
Before in situ hybridization analysis, the specificity of the
RNA probe and the accumulation of viral RNA of the dif-
ferent TMV constructs used in this study (Fig. 1 A) were
analyzed by Northern blot hybridization (Fig. 1 B). Total
RNAs from equal numbers of protoplasts were extracted
at different times after infection and subjected to North-
ern hybridization with a probe labeled with digoxigenin
(dig-RNA). The RNA probe contains a fragment of the
replicase sequence (see details in Materials and Methods).
The probe hybridized with an RNA of 
 
z
 
6.4 kb, represent-
ing the full-length, plus-strand genome of TMV (Fig. 1
B, w.t.). As anticipated, vRNA accumulated to approxi-
mately the same level in cells infected with wt TMV RNA
and in cells infected with TMV RNA that lacked the MP
(
 
D
 
M), confirming previous studies showing that the MP is
not required for replication (Meshi et al., 1987). RNAs
from mock-inoculated protoplasts did not react with the
probe (Fig. 1 B, Mock).
Time-course analysis showed that vRNA accumulated
to detectable levels at 4 hpi, increased until 14 hpi, and
then gradually decreased to a lower level through 30 hpi
(Fig. 1 B). The levels of accumulation of vRNA in mutants
that lack the CP sequence and express the MP:GFP fusion
protein (MP:GFP-
 
D
 
C in Fig. 1) were somewhat lower than
in wt infection, especially at 30 hpi (Fig. 1 B). Since MP:
GFP-
 
D
 
C produced no CP, the lower levels of vRNA in
these samples are presumed to reflect the lack of encapsi-
dated vRNA. Protoplasts infected with RNAs derived
from constructs containing the CP open reading frame and
MP:GFP fusion protein (MP:GFP-CP) showed lower lev-
els of vRNA than those observed in wt infection (compare
wt and MP:GFP-CP in Fig. 1 B).
The levels of ribosomal RNAs in each sample were sim-
Figure 1. (A) Diagrammatic representation of the genomic struc-
tures of wt TMV RNA and derivatives used in this study (indi-
cated in the left margin). Coding regions for the replicase, MP,
GFP, and CP are shown by open boxes. Broken lines represent
fusion proteins (MP fused to GFP), while solid lines represent ex-
pression of free proteins. (B) Accumulation of genome-length
TMV plus-strand RNA in tobacco protoplasts inoculated with wt
TMV RNA (w.t.) and with different TMV derivatives (indicated
above each lane). “Mock” corresponds to protoplasts treated in
absence of inoculum. Total RNA was extracted at 4, 14, and 30
hpi, glyoxylated, and subjected by electrophoresis on a 1% dena-
turing agarose gel. Northern blots were probed with a digoxige-
nin-labeled RNA probe that recognized the plus strand of TMV
RNA. Each construct was tested in at least three independent ex-
periments; results consistent with those shown were obtained in
each experiment. 
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ilar, as visualized by staining with methylene blue before
hybridization (not shown).
When samples were hybridized with a probe to detect
minus-strand RNA, the signal was observed only at early
stages of infection (4–8 hpi) and in much lower amounts
than plus strands (not shown). Similar results were de-
scribed by Ishikawa et al. (1991) in TMV (L strain)-infected
protoplasts.
These studies show that the nonradioactive RNA
probes were sufficiently sensitive and specific for use in
situ hybridization procedures. They also indicate that
vRNA produced by wt, 
 
D
 
M, and MP:GFP virus infections
accumulate to approximately the same degree throughout
infection.
 
Subcellular Distribution of TMV Genomic RNA in 
Infected Protoplasts
 
The intracellular accumulation of TMV RNA during in-
fection was visualized by in situ hybridization. Protoplasts
isolated from BY-2 tobacco cells were transfected with wt
RNA, collected at different times after infection, and hy-
bridized with fluor-RNA probes. The fluorescent signals
were visualized by confocal microscopy after collecting
optical sections with a focal depth of 0.8 
 
m
 
m. Since infec-
tion of BY-2 protoplasts is apparently not synchronous
(Heinlein et al., 1998), the accumulation of vRNA was
considered in three stages: early, 6–12 hpi; mid, 12–22 hpi;
and late, 22–36 hpi. Representative examples are shown in
Fig. 2. At early stages of infection (Fig. 2, A–C), vRNA
was primarily localized in faint fluorescent vesicle-like
structures surrounding the nucleus (Fig. 2 A). The fluores-
cent signal was also observed in small, discrete cytoplasmic
patches of uniform size, dispersed randomly throughout
the cell (Fig. 2 B, arrowheads). In some cells, vRNA
tended to accumulate in large amounts around the nucleus
as shown in an optical section in Fig. 2 C.
At midstages of infection (Fig. 2, D–I), vRNA was asso-
Figure 2. Intracellular distribution of vRNA in protoplasts infected with wt vRNA. Protoplasts were collected at different times after
infection, fixed, and hybridized with a fluorescein-RNA probe that recognized TMV RNA. Fluorescent signals were visualized by con-
focal microscopy, collecting optical sections with a focal depth of 0.8 mm. (A–C) At early stages of infection (6–12 hpi), vRNA is associ-
ated with vesicle-like structures surrounding the nucleus (A) and in small patches or particles in the cytoplasm (B and C). Note the large
amount of vRNA in perinuclear regions (C). (D–I) vRNA at midstages of infection (12–22 hpi) localized in large and small bodies (D
and E), a weakly fluorescent reticulated network (E), large vesicles (F), large bodies (G) that appear to be associated with filaments (H
and I). (J and K) vRNA at late stages of infection (22–36 hpi). vRNA is associated with small, intensely labeled spots around the nu-
cleus, dispersed throughout the cytoplasm, and at the periphery of the cell (J) and localized in filamentous structures, some of which
protrude from the surface of the cells (K). (L) Mock-inoculated protoplasts identically processed and imaged. The images shown in A,
B, K, and L correspond to projections of serial optical sections, while C, D, F–H, and J represent single optical sections. Bars: (A–D
and F–G) 10 mm; (E–I) 5 mm. 
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ciated with large irregularly shaped bodies (Fig. 2 D, ar-
rowheads). High magnification of the image revealed that
these bodies were, in many cases, associated with a weakly
fluorescent reticulated network (Fig. 2 E) that resembled
the cortical ER. Short fluorescent strands of tubules, small
fluorescent circles, and vesicles of variable size and shape
were also observed (Fig. 2 F, arrows). During the mid-
dle stage of infection, most of the large bodies were local-
ized around the nucleus, although some were dispersed
throughout the cytoplasm (Fig. 2 D) and in some cells oc-
cupied much of the cytoplasm (Fig. 2 G). Clear localiza-
tion of vRNA in filamentous structures was visible during
this period (Fig. 2, H and I); most of the filaments ap-
peared to be associated with the fluorescent bodies (Fig. 2,
H and I). At late stages of infection (Fig. 2, J and K),
vRNA was localized to small, intensely labeled spots
around the nucleus, throughout the cytoplasm, and at the
periphery of the cell (Fig. 2 J). The number and intensity
of these spots decreased over time. By 40 hpi, 15% of in-
fected protoplasts showed vRNA localized to elongated
structures that appeared to protrude through the plasma
membrane (Fig. 2 K, arrowheads). The protrusions resem-
bled those previously described as binding the MP:GFP
fusion protein (Heinlein et al., 1998; Más and Beachy,
1998).
We conclude from these studies that vRNA accumulates
in different subcellular compartments throughout infec-
tion. This compartmentalization most likely reflects the
roles of vRNA in replication, translation, and assembly in
viral particles.
Mock-inoculated protoplasts identically processed and
imaged did not show fluorescent signals (Fig. 2 L). In addi-
tion, no signal was observed when either the fluor-RNA
probe was omitted from the hybridization reaction or
when the samples were treated with RNAse A before the
hybridization reaction (not shown). Furthermore, 90–95%
of the inoculated protoplasts showed hybridization signal,
coinciding with the percentage of protoplasts that are in-
fected after inoculation with wt vRNA.
As anticipated from the Northern hybridization studies
described above and those described by Ishikawa et al.
(1991), in situ hybridization experiments using a probe
that bound minus-strand RNA revealed fluorescent sig-
nals only at early stages of infection (4–8 hpi). As illus-
trated in Fig. 3, fluorescence accumulated primarily in
perinuclear vesicles and in small cytoplasmic patches, sim-
ilar to the accumulation of plus-strand vRNA (compare
with Fig. 2 B). Interestingly, the surface of the nucleus was
not uniformly covered by fluorescence in these reactions.
In protoplasts visualized at 4–6 hpi, the fluorescent signal
was clearly absent from a discrete region of most nuclei
(Fig. 3 B). Visualization at high magnification revealed cir-
cular regions free of RNA in protoplasts with weak (Fig. 3
C) or strong (Fig. 3 D) fluorescence around the nucleus.
Taken together, these results indicate that the fluores-
cent signal obtained after in situ hybridization of U1-
infected protoplasts reflects the intracellular distribution
of TMV RNA.
 
Spatial Relationships between vRNA and Viral Proteins
 
Viral RNA Colocalizes with the Replicase.  
 
To examine the
 
relationship between the sites of vRNA accumulation and
the location of the viral replicase, protoplasts infected with
wt TMV RNA were collected at early stages of infection,
first immunostained with antibody raised against the TMV
replicase protein (Nelson et al., 1993), and subsequently
processed for in situ hybridization with the fluor-RNA
probe. The distribution of the replicase, visualized with
TRITC-conjugated secondary antibody (Fig. 4, red) was
similar to that of vRNA (green). Superimposition of coin-
cident green and red signals are presented in yellow
(merged image) and are most apparent in bodies and fila-
ments in the cytoplasm. The antireplicase antibody also la-
beled structures that lacked vRNA (red in merged image).
It is not known whether these differences reflect differ-
ences in distribution of replicase protein and vRNA or dif-
ferences in intensity of each fluorophore.
In double labeling experiments, the fluorophores were
scanned independently to minimize crossover between the
two channels. Similar patterns of distribution of replicase
were observed when the samples were processed only by
immunostaining with the replicase antibody, indicating
that the results were not due to artifacts produced as a re-
sult of the in situ hybridization procedure.
 
Viral RNA Colocalizes with the MP.  
 
The patterns of
vRNA accumulation over time resembled the pattern of
synthesis, accumulation, and degradation of the MP dur-
ing TMV infection (Heinlein et al., 1998; Más and Beachy,
1998). To investigate the spatial relationship between
vRNA and MP, protoplasts infected with vRNA-MP:
GFP-CP were hybridized with the digoxigenin-RNA
probe and hybridization was visualized by immunostaining
with a rhodamine antidigoxigenin antibody. The distribu-
tion of vRNA-MP:GFP-CP was similar to that of vRNA in
wt infection, indicating that the presence of the MP:GFP
fusion protein did not significantly alter the pattern of
vRNA distribution. Similar patterns of fluorescence were
also observed in protoplasts infected with vRNA-MP:
GFP-
 
D
 
C, a mutant virus that expresses the MP:GFP fu-
sion and lacks the CP sequence (not shown).
The hybridization procedure was incompatible with si-
multaneous detection of MP:GFP due to bleaching of GFP
fluorescence during the treatment of the samples. There-
fore, to compare the accumulation of both the MP and
vRNA in the same cell, protoplasts infected with vRNA-
MP:GFP-
 
D
 
C were harvested at midstages of infection,
fixed, and spun onto poly-lysine–coated slides (see Materi-
als and Methods). Cells showing the characteristic fluores-
cence pattern of MP:GFP accumulation as previously de-
scribed (Heinlein et al., 1998; Más and Beachy, 1998) were
scanned using the 488-nm argon laser of the confocal mi-
croscope and the samples were then processed for in situ
hybridization. Before the hybridization reaction, the cells
were imaged to verify the absence of fluorescence due
to GFP.
After hybridization with the fluor-RNA probe, the sam-
ples were examined to detect the products of hybridization
(vRNA). As shown in Fig. 5, there was a striking coinci-
dence between the distribution of MP and the sites of
vRNA accumulation. vRNA was also found in small cyto-
plasmic patches that lacked detectable MP (arrows). Simi-
lar patterns of distribution of replicase, MP, and vRNA
distribution confirmed the hypothesis that the replication 
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of vRNA and the accumulation of the MP occur at the
same subcellular sites.
 
Role of the MP in Establishing the Sites of RNA Accumula-
tion in Infected Cells.  
 
As shown above, MP colocalizes with
the main sites of vRNA accumulation during TMV infec-
tion. To clarify the role of the MP in establishing the sites
of virus replication, protoplasts infected with vRNA-
 
D
 
M
were processed for in situ hybridization. At early stages of
infection, a similar pattern of fluorescence was observed
in protoplasts infected with wt vRNA or vRNA-
 
D
 
M. The
fluorescent signal was localized in vesicle-like structures
surrounding the nucleus and in small cytoplasmic patches
(Fig. 6 A). In contrast to infection by wt TMV, vRNA-
 
D
 
M
also accumulated in stacks of tubular structures near the
nucleus (Fig. 6 B, arrowheads). Higher magnification re-
vealed vesicles of different sizes (2–5 
 
m
 
m diameter)
around the nucleus as well as throughout the cytoplasm
(Fig. 6 C, arrowheads). At midstages of infection, the
most striking feature that distinguished this pattern of
vRNA-
 
D
 
M distribution from that of wt vRNA was the ab-
sence of large fluorescent bodies. Instead, smaller fluores-
cent spots were distributed throughout the cell, intercon-
nected by fewer fluorescent reticulated strands than in wt
infection (Fig. 6 D, arrowheads). We often observed
stacks of large lamellar cisternae that were up to 10 
 
m
 
m in
length and 4–5 
 
m
 
m in depth (Fig. 6 E, arrows). At late
stages of infection, the fluorescent signal was observed
only as small, intensely labeled spots around the nucleus
and scattered throughout the cytoplasm (Fig. 6 F). Cells
infected with vRNA-
 
D
 
M did not exhibit fluorescent pro-
Figure 3. Intracellular distribution of TMV minus-strand RNA
in protoplasts infected with wt RNA. Protoplasts collected at
early stages of infection (4–6 hpi) were fixed and hybridized with
a fluorescein-RNA probe that recognized the complementary
strand of vRNA. (A) Minus-strand RNA accumulation in a peri-
nuclear pattern and in small cytoplasmic patches. (B) RNA sur-
rounding the nucleus with a discrete region that lacked hybridiza-
tion. (C and D) Nuclei of protoplasts at 6 hpi showing vRNA-free
zone. A, C, and D correspond to single optical sections, while B
corresponds to a projection of serial optical sections. N, nucleus.
Bars: (A and B) 10 mm; (C and D) 5 mm.
Figure 4. vRNA colocalizes with the replicase.
Protoplasts infected with wt vRNA were fixed at
early stages of infection and processed for immu-
nofluorescence using antireplicase antibody and in
situ hybridization for detecting vRNA. Most of the
replicase (red signal) was localized in sites were
vRNA (green signal) accumulated. Merging both
images demonstrates colocalization of both signals
(yellow in merged image). N, nucleus. Bars, 10 mm. 
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trusions from the surface of the cells as in cells infected
with wt vRNA (e.g., Fig. 2 K).
Similar distribution of vRNA was observed when proto-
plasts were infected with vRNA-
 
D
 
M-GFP-
 
D
 
C, a virus con-
 
struct that lacks CP and MP and produces free GFP (not
shown).
 
Spatial Relationship between Viral RNA and
Host Components
 
Viral RNA Colocalizes with the Endoplasmic Reticulum. 
 
As
noted above, the reticulated pattern of fluorescence that
represents the location of wt vRNA resembled the distri-
bution of the ER. Furthermore, previous studies demon-
strated colocalization of TMV MP and the replicase with
ER on the fluorescent irregularly shaped bodies (Heinlein
et al., 1998; Reichel and Beachy, 1998). To determine if
vRNA is associated with the ER, in situ hybridization was
performed on protoplasts collected at early stages of infec-
tion. The samples were also stained using an antibody to
the ER BiP (Boston et al., 1996) and a TRITC-conjugated
secondary antibody. As shown in Fig. 7, BiP was localized
to perinuclear areas and small aggregates dispersed in the
cytoplasm. vRNA was localized in structures surrounding
the nucleus and scattered in the cytoplasm and in fluores-
cent bodies. After superimposing the images, we con-
cluded that a portion of the vRNA detected is associated
with the ER (yellow in merged image). BiP and vRNA
were not fully coincident, indicating that a fraction of
vRNA was independent of the ER.
In protoplasts treated at early stages of infection with 50
 
m
 
g/ml of Brefeldin A (BFA), a fungal metabolite that dis-
rupts the endomembrane system in plant cells (Henderson
et al., 1994; Satiat-Jeunemaitre et al., 1996), the vRNA was
dispersed throughout the cytoplasm in small fluorescent
spots. No fluorescent vesicle-like structures were observed
surrounding the nucleus in treated samples (Fig. 8). These
Figure 5. vRNA colocalizes with the MP.
Protoplasts infected with vRNA-MP:GFP-
DC (see Fig. 1) were fixed at midstages of
infection, and the pattern of MP accumula-
tion was observed as fluorescence emitted
by the MP:GFP. The samples were then
treated to eliminate fluorescence by GFP
and hybridized with the fluor-RNA probe to
detect vRNA. A cell showing the MP distri-
bution was identified by its position and
shape and visualized to detect the products
of hybridization (vRNA). Comparison of
both images reflects colocalization of MP:
GFP and vRNA. N, nucleus. Bars, 10 mm.
 
Figure 6
 
. Intracellular distribution of vRNA-
 
D
 
M. Infected proto-
plasts were fixed and hybridized with a fluorescein-RNA probe
to localize vRNA. Fluorescence was visualized by confocal mi-
croscopy of optical sections with a focal depth of 0.8 
 
m
 
m. (A–C)
Accumulation of vRNA-
 
D
 
M at early stages of infection in vesi-
cle-like structures surrounding the nucleus and in small cytoplas-
mic patches (A) and in stacks of tubular strands (B). vRNA-
 
D
 
M
was also associated with small vesicles surrounding the nucleus
and throughout the cytoplasm (C). At midstages of infection,
 
vRNA-
 
D
 
M was observed in bright fluorescent spots intercon-
nected by short filaments (D) and in stacks of lamellar structures
(E). At late stages of infection (F), fluorescent signal was ob-
served only in small, intensely labeled spots around the nucleus
and scattered throughout the cytoplasm. Note the absence of
vRNA-
 
D
 
M in association with large fluorescent bodies or with
clearly defined filaments. A corresponds to the projection of 12
serial optical sections, while B–F correspond to single optical sec-
tions. N, nucleus. Bars: (A, B, E, and F) 10 
 
m
 
m; (C and D) 5 
 
m
 
m. 
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results corroborate the hypothesis that at early stages of
infection vRNA is associated with ER.
 
Viral RNA Colocalizes with Microtubules. 
 
At early and
midstages of infection, vRNA was associated with fluores-
cent cytoplasmic filaments (Fig. 2, H and I). To determine
if vRNA is associated with elements of the cytoskeleton,
infected protoplasts that were immunostained with a mono-
clonal antibody to 
 
a
 
-tubulin were processed for in situ hy-
bridization. A variety of different experimental conditions
was evaluated before selecting conditions that permitted
visualization of both signals. The procedure that was used
involved treating fixed protoplasts with 1 
 
m
 
g/ml of protein-
ase K for 5 min to partially digest cross-linked proteins
and subsequent refixation to avoid disintegration of the
cells. These procedures improved the accessibility of the
probe while preserving the integrity of the microtubules.
Fig. 9 shows confocal micrographs of tubulin (in red) and
vRNA (in green) in an infected protoplast processed at
midstage of infection. Merging the images clearly showed
the coalignment of both signals (merged image). Most
of the green fluorescent filaments corresponding to sites
of vRNA accumulation coaligned with the cytoplasmic
strands of microtubules (Fig. 9 A, yellow in merged im-
age). Furthermore, some of the bright fluorescent spots
that contained vRNA accumulated in tracks that were
aligned with microtubule filaments (Fig. 9 B).
Protoplasts infected with vRNA-
 
D
 
M that were identi-
cally processed and imaged did not show fluorescent sig-
nals associated with cytoskeleton (except in cytochalasin
D–treated protoplasts, see below). The results indicate
that colocalization of vRNA with microtubules was not
due to artifactual aggregation that occurred during fixa-
tion procedures. These conclusions are based on repli-
cated data, either in the number of experiments or in the
number of protoplasts analyzed per experiment.
In companion studies, we attempted to stain with antiac-
tin antibodies and with the probe for vRNA. However, we
did not resolve a typical pattern of filamentous actin distri-
bution (not shown). Most of the cells showed very short
fluorescent strands of actin dispersed throughout the cyto-
plasm. In some cells, we observed a coincidence between
the short strands of TRITC-fluorescent signal and vRNA
(not shown). It is possible that under the conditions of
Figure 7. vRNA colocalizes with BiP (ER
marker). Protoplasts infected with wt vRNA
were fixed at early stages of infection and pro-
cessed for immunofluorescence using anti–BiP
antibody and in situ hybridization. Most of the
BiP (red) was associated with sites that contain
vRNA (green). Merging the two images demon-
strates colocalization of the signals (yellow in
merged image). Bars, 10 mm.
Figure 8. Disruption of the
ER induces changes in the lo-
calization of wt vRNA. In
protoplasts treated at early
stages of infection with 50 mg/
ml of BFA, the vRNA was
accumulated in small fluores-
cent spots dispersed through-
out the cytoplasm (vRNA/
BFA). Note the absence of
the perinuclear fluorescent
structures that accumulate in
nontreated protoplasts (see
Fig. 2, A–C, for compari-
sons). N, nucleus. Bar, 10 mm. 
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these experiments, the integrity of the microfilaments was
not maintained. A relationship between actin filaments
and vRNA can not be ruled out since disruption of mi-
crofilaments by treating infected protoplasts with cyto-
chalasin D altered the pattern of vRNA distribution (see
below).
 
Effects of Cytoskeletal Inhibitors on Localization of vRNA.
 
The results provide strong evidence for colocalization of
vRNA with microtubules and suggest that cytoskeletal el-
ements may be involved in distribution of vRNA in proto-
plasts. To clarify the role of the cytoskeleton in vRNA
distribution, protoplasts infected with wt vRNA were
treated with specific cytoskeletal inhibitors and vRNA ac-
cumulation was examined by in situ hybridization. Repre-
sentative examples are shown in Fig. 10. Treatment of pro-
toplasts at early stages of infection with oryzalin, a plant
microtubule depolymerizing agent (Hugdahl and More-
john, 1993), abolished the accumulation of vRNA around
the nucleus and most vRNA was dispersed throughout the
cytoplasm (not shown). When oryzalin was added at mid-
stages of infection, nearly all of the fluorescence was asso-
ciated with enlarged fluorescent bodies on or near the nu-
clear envelope (Fig. 10, vRNA/Oryzalin). In nontreated
protoplasts, most of the fluorescent bodies were dispersed
throughout the cytoplasm at this stage of infection (e.g.,
Fig. 2 G). When oryzalin was added late in infection, we
did not observe changes in distribution of vRNA. In
treated as well as nontreated protoplasts, vRNA was asso-
ciated with the filament-like structures protruding from
the surface of the cells (see Fig. 2 K).
In protoplasts treated during early stages of infection
with cytochalasin D, there was a clear delay in the forma-
tion of the cytoplasmic bodies compared with nontreated
protoplasts. Interestingly, the pattern of vRNA accumula-
Figure 9. vRNA colocalizes
with microtubules. Proto-
plasts infected with wt
vRNA were fixed and
processed for immunofluo-
rescence using antitubulin an-
tibody and in situ hybridiza-
tion. (A) Most of the tubulin
(red) was associated with fila-
ments that coaligned with the
filaments that contain vRNA
(green). Merging the images
demonstrates colocalization
of the signals (yellow in
merged image). (B) Some of
the bright fluorescent patches
containing vRNA (green) ap-
pear to be aligned with micro-
tubule filaments (red). Bars,
(A) 10 mm; (B) 2 mm.
Figure 10. Disruption of cytoskele-
ton induces changes in the localiza-
tion of wt vRNA and vRNA-DM.
Protoplasts treated at midstages of
infection with 10 mM oryzalin for 2 h
induces the accumulation of vRNA
in enlarged fluorescent bodies sur-
rounding the nucleus (vRNA/Oryza-
lin). Treatment at early stages of in-
fection with cytochalasin D delays
the formation of large bodies, and
the pattern of vRNA accumulation
was similar to that observed in infec-
tion by vRNA-DM (vRNA/Cytoch D). In protoplasts infected with vRNA-DM and treated at early stages of infection with cytochalasin
D, vRNA-DM accumulated in filaments and narrow structures at the periphery of the cell (vRNA-DM/Cytoch D). Bars, 10 mm. 
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tion in cytochalasin D–treated cells was similar to that ob-
served in cells infected with vRNA-
 
D
 
M (compare Fig. 10,
vRNA/Cytoch D, with Fig. 6). At midstages of infection,
at a time when the large cytoplasmic bodies were formed,
the vRNA in cytochalasin D–treated protoplasts (not
shown) was detected in enlarged bodies that appeared as
more elongated structures than those observed in non-
treated cells.
In protoplasts infected with vRNA-
 
D
 
M and treated with
cytochalasin D at early stages of infection, vRNA-
 
D
 
M was
associated with filaments resembling microtubules (Fig.
10, 
 
D
 
M/Cytoch D). In these protoplasts, vRNA-
 
DM also
accumulated at the periphery of the cell, but no fluores-
cence was observed around the nucleus or in small bodies
throughout the cytoplasm, as in the case of nontreated,
vRNA-DM–infected protoplasts (see Fig. 6 for compari-
sons). The effects of cytochalasin D were more dramatic in
infections with vRNA-DM than with wt vRNA, suggesting
an influence of the MP in the localization of vRNA in cy-
tochalasin D–treated protoplasts.
The results of these studies demonstrate that disruption
of the cytoskeleton produces changes in the pattern of vRNA
localization and suggest an important role of microtubules
and microfilaments in the distribution of vRNA during vi-
rus infection.
Discussion
Early Stages of TMV Infection
The replication of many positive-strand RNA viruses oc-
curs in close association with membranes (e.g., Wu et al.,
1992; Molla et al., 1993; Strauss and Strauss, 1994; Osman
and Buck, 1996). In this study, TMV vRNA was specifi-
cally localized with several types of cellular membranes.
Early in infection, vRNA was associated with a perinu-
clear reticulated network and with strands of tubules and
small vesicles. These structures closely resembled the cor-
tical polygonal ER network of tubules and sheets with in-
tervening lamellar segments connected to the nuclear en-
velope, previously described in plant cells (Allen and
Brown, 1988; Hepler et al., 1990; Staehelin, 1997). Colocal-
ization of vRNA with BiP, a resident protein of the ER
(Denecke et al., 1995; Boston et al., 1996) and the disrup-
tion of the fluorescent structures by BFA (Fig. 8), support
the hypothesis that vRNA is associated with ER. Our ob-
servations that viral replicase (Ishikawa et al., 1986) and
the complementary minus-strand RNA (used as template
for vRNA replication) were localized in these membra-
nous structures strongly suggest that replication of TMV
vRNA takes place in close association with the ER. Ear-
lier reports described a relationship between TMV repli-
cation complexes and membranous extracts from infected
cells (Watanabe and Okada, 1986; Osman and Buck,
1996).
Minus-strand RNA was also localized to structures (pre-
sumed to be ER) that surround the nucleus, with the ex-
ception of a discrete region. The absence of minus-strand
RNA from this region could reflect compartmentalization
of the perinuclear ER, or it may indicate that the ER is di-
vided into subdomains with specific morphological or
functional properties (Staehelin, 1997). Ishikawa et al.
(1986) suggested that the synthesis of plus and minus
strands of vRNA requires different types of factors or mo-
lecular interactions, an observation that may have rele-
vance to our studies.
vRNA and viral replicase were colocalized in small
patches that are distributed throughout the cytoplasm. As
previously indicated in poliovirus infection (Bienz et al.,
1983), we suggest that patches that contain vRNA and rep-
licase correspond to replication complexes in association
with ER that compartmentalize the required components
of replication to enhance virus production.
At early stages of infection, vRNA was associated with
fluorescent filaments that resembled elements of the cy-
toskeleton (not shown). Based on the effects of oryzalin
and cytochalasin D on the distribution of vRNA in the cy-
toplasm, we suggest that there is association of vRNA with
the cytoskeleton at a very early stage of infection. In this
scenario, vRNA exploits the cytoskeleton for transport
from the cytoplasm to perinuclear positions. This hypothe-
sis is based in part on the observation that treating proto-
plasts with oryzalin at the time of inoculation prevented
the localization of vRNA to the perinuclear region. A re-
cent report described a mechanism in newt lung epithelial
cells by which the ER membranes attached to microtu-
bules are transported toward the cell center through acto-
myosin-based retrograde flow of microtubules with ER at-
tached as cargo (Waterman-Storer and Salmon, 1998).
Following this model, it is possible that vRNA-replicase
complexes associated with ER are transported via micro-
tubules to perinuclear positions using a similar mecha-
nism.
Throughout the infection, vRNA was localized in differ-
ent subcellular compartments. We suggest that this reflects
movement of vRNA to different compartments, but can-
not eliminate the possibility that compartmentalization
represents the synthesis and subsequent degradation of
vRNA rather than movement of vRNA from one com-
partment to another.
When protoplasts were infected with vRNA-DM, a mu-
tant of TMV that does not produce MP, vRNA-DM was
localized to vesicle-like structures around the nucleus and
in small patches in the cytoplasm. These results indicate
that at an early stage of infection, association with the ER
is an intrinsic property of vRNA and/or the replicase and
does not require MP. It is possible that vRNA contains se-
quences that target to the ER. Some cellular mRNAs are
known to contain specific signals that direct them to the
rough ER for translation (St. Johnston, 1995).
Midstages of Infection: Virus Accumulation and 
Intracellular Transport
At midstages of infection, vRNA was localized in fluores-
cent, irregularly shaped bodies, some of which were vesi-
cle-like in appearance. Furthermore, the replicase (Fig. 4)
and MP (Fig. 5) colocalized with vRNA on these bodies.
Since such structures were not observed in protoplasts in-
fected with vRNA-DM, we conclude that MP is required
for the formation and/or stabilization of the bodies. These
structures may correspond to the previously described
“viroplasms or amorphous inclusions” induced by TMV
infection (Martelli and Russo, 1977). Our observationsMás and Beachy Replication of Tobacco Mosaic Virus 955
support an earlier suggestion that replication complexes
associated with rough ER function as mRNAs (Beachy
and Zaitlin, 1975). During its synthesis, MP may remain
associated with vRNA, acting as an anchoring protein and
trapping vRNA on ER-derived structures. Accordingly,
the large accumulation of MP is coincident with dramatic
morphological changes that take place on the ER (Reichel
and Beachy, 1998).
Over time, the cytoplasmic bodies become elongated
structures, often associated with fluorescent filaments, di-
rected toward the periphery of the cell. Immunostaining
with antitubulin antibody and in situ hybridization reac-
tions provide clear evidence of colocalization of vRNA
with microtubules. Treatment of protoplasts at midstage
of infection with oryzalin prevented the dispersion of the
bodies to the periphery of the cell, suggesting that micro-
tubules play a role in intracellular distribution of vRNA.
Two different microtubule-based mechanisms, membrane
sliding and tip attachment complexes, participate in the
movement of ER from the cell center to the periphery of
newt lung epithelial cells (Waterman-Storer and Salmon,
1998). In TMV infection, the complexes that contain MP,
Figure 11. Model of TMV infection in BY2 protoplasts. (1) Early in infection, TMV vRNA comes in close association with membranes
of the ER, and vRNA-replicase complexes associated with ER are transported via microtubules to perinuclear positions. (2) Nascent
vRNAs synthesize MP that remains associated with vRNA. (3) Formation and anchoring of large ER-derived structures containing MP,
replicase, and vRNA that are stabilized by MP and microfilament interactions. (4) Microtubule-based transport system of vRNA-MP
complexes towards the periphery of the cell to initiate cell-to-cell spread. (5) Protrusion of ER containing vRNA and MP through the
plasma membrane. Note that the model is not drawn in scale.The Journal of Cell Biology, Volume 147, 1999 956
vRNA, and replicase that are associated with ER may be
transported towards the periphery of the cells using such
mechanisms.
Treatment of infected protoplasts with cytochalasin D
clearly altered the pattern of vRNA distribution and
caused a delay in the appearance of the large bodies, sug-
gesting a role of microfilaments in their formation and/or
stabilization. However, depolymerization of microtubules
can also lead to disruption of microfilaments (Panteris et al.,
1992); it is therefore difficult to define the specific role of
each cytoskeletal component in the intracellular spread of
vRNA.
vRNA-DM was not associated with elements of the cy-
toskeleton unless the cells were treated at early stages of
infection with cytochalasin D. Such treatment resulted in
accumulation of vRNA-DM in fluorescent spots at the pe-
riphery of the cell, as well as on filaments that were similar
in appearance to microtubules. These results suggest that
vRNA was associated with microtubules when both MP
and microfilaments were absent. The transport of mRNAs
along cytoskeletal components has been described in a va-
riety of biological systems, especially in relation to cell dif-
ferentiation and development (Ferrandon et al., 1994;
Kloc and Etkin, 1995; Ainger et al., 1997; Broadus et al.,
1998). In those cases, RNA transport mechanisms in-
volved specific sequences in the 39 untranslated region
that are recognized by proteins that bind these sequences
and mediate the interaction with the cytoskeleton (Oleyni-
kov and Singer, 1998). In our study, the change in the dis-
tribution pattern of vRNA that is induced by cytochalasin
D was more evident in protoplasts infected with vRNA-
DM vs. wt vRNA. These data suggest some influence of
the MP in localization of vRNA in cytochalasin D–treated
protoplasts. The implications of MP and microfilaments in
the formation and anchoring of the cytoplasmic bodies are
discussed below.
Late Stages of Infection: Virus Spread
and/or Degradation?
Throughout infection, vRNA was localized around the nu-
cleus, although at mid and late stages, vRNA was also dis-
persed throughout the cytoplasm and at the periphery of
the cell. Accumulation of vRNA around the nucleus may
facilitate association with host components that are re-
quired for virus infection. However, the accumulation of
the much larger bodies that surround the nucleus may im-
ply a different biological role in replication. Recently, a
model was proposed by which misfolded proteins that es-
cape the proteosome-mediated pathway of degradation
can aggregate to form large structures, referred to as “ag-
gresomes.” Aggresomes are transported on microtubules
from peripheral sites to a ubiquitin-rich nuclear location at
the microtubule-organizing center, where they are entan-
gled with collapsed intermediate filaments (Johnston et
al., 1998). Following this model, during TMV infection, the
bodies that contain MP, vRNA, and replicase may be
transported on microtubules in order to be degraded. In
other recent studies, we described the ubiquitination of
MP and the role of proteosomes in degradation of MP (C.
Reichel and R.N. Beachy, manuscript submitted for publi-
cation).
At late stages of infection, vRNA was localized in struc-
tures that protrude from the surface of the cell. These pro-
trusions were not disrupted by oryzalin or cytochalasin D.
Furthermore, in other studies, we observed that the pro-
trusions were stained with DiOC6(3) (3, 39-dihexyloxacar-
bocyanine iodide), a vital fluorescent stain of ER (not
shown). Other studies indicate that these ER-containing
structures are not induced by virus infection per se, but
may be stimulated by infection (P. Más and R.N. Beachy,
manuscript in preparation). We propose that the protrud-
ing structures are related to desmotubules, the appressed
ER that comprises the central component of plasmodes-
mata (Lucas et al., 1993). Alternatively, they could be a
consequence of cell damage at late stages of infection,
which results in the extrusion of ER through the plasma
membrane. Interestingly, vRNA-DM was not associated
with the protrusions, indicating a role of the MP in local-
ization of vRNA with these structures. Together, these re-
sults may imply that at least two different types of ER are
involved in TMV infection. One type of ER is involved in
vRNA replication and does not require the presence of
the MP. A second type corresponds to the filamentous
protrusions that may be involved in the intercellular
spread of the virus and requires a functional MP.
Model of TMV Infection
The data presented here and in previous publications are
consistent with a model of TMV infection (Fig. 11) in
which the replication of vRNA takes place in close associ-
ation with membranes of the ER (Fig. 11, 1). In this
model, cytoskeletal elements are involved in targeting
vRNA/replicase complexes to the perinuclear ER, per-
haps via a retrograde flow of microtubules with ER at-
tached as cargo. The ER-associated nascent vRNAs in
replication complexes function as mRNAs for the synthe-
sis of MP (Fig. 11, 2). The MP remains associated with
vRNA in the complex, resulting in the formation of large
ER-derived structures (Fig. 11, 3). At this point, the distri-
bution of vRNA would be determined by a balance be-
tween the formation and anchoring of the large structures
and their spread towards the periphery of the cell. Our re-
sults are consistent with a model in which MP and mi-
crofilaments participate in the formation and anchoring of
the ER-derived structures (Fig. 11, 3), while microtubules
are involved in the transport to their final destinations; i.e.,
to the periphery for intercellular spread, or toward the nu-
cleus for degradation (Fig. 11, 4).
Several types of experimental evidence support this
model. First, there is a dramatic effect on distribution of
vRNA-DM in cytochalasin D–treated protoplasts. Not
only were bodies not found in these protoplasts, in
contrast to wt vRNA, but vRNA-DM was located on or
near the cell periphery but not in the protrusions from
the plasma membrane. Since in nontreated protoplasts
vRNA-DM was not localized at the periphery in early
stages of infection, the intracellular spread that normally
occurs later in infection was apparently accelerated in the
absence of microfilaments. Second, the clear association of
vRNA-DM with microtubules would explain the role of
microtubules in the intracellular spread of the virus to-
wards the periphery of the cell. Third, at late stages of in-Más and Beachy Replication of Tobacco Mosaic Virus 957
fection, the close relationship between the ER and micro-
tubules explains the association of vRNA in the presence
of the MP to a precursor of the plasmodesmata (Fig. 11, 5)
that would result in the cell-to-cell spread of the virus in
leaf tissues.
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